Prothrombotic polymorphisms, mutations, and their association with pediatric non-cardioembolic stroke in Asian-Indian patients

被引:24
|
作者
Biswas, Arijit [1 ]
Tiwari, Arun Kumar [2 ]
Ranjan, Ravi [1 ]
Meena, Arvind [1 ]
Akhter, Mohammad Suhail [1 ]
Yadav, Birendra Kumar [1 ]
Behari, Madhuri [3 ]
Saxena, Renu [1 ]
机构
[1] All India Inst Med Sci, Dept Hematol, New Delhi 110029, India
[2] Ctr Addict & Mental Hlth, Dept Neurogenet, Toronto, ON, Canada
[3] All India Inst Med Sci, Dept Neurosci, New Delhi 110029, India
关键词
Pediatric stroke; Thrombosis; Polymorphism; Association; METHYLENETETRAHYDROFOLATE REDUCTASE GENE; FACTOR-V-LEIDEN; ISCHEMIC-STROKE; RISK-FACTORS; HOMOCYSTEINE; COMMON; POPULATION; CHILDREN; A1298C; IIIA;
D O I
10.1007/s00277-008-0613-6
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Genes involved in the hemostatic mechanism are logical candidate genes for association studies in prothrombotic conditions such as stroke. Since the underlying etiology in pediatric strokes is different than adults, looking for genetic causes would be the logical thing to do in the pediatric stroke population. Fifty-eight Asian-Indian stroke patients below 15 years of age and equal number of age- and sex-matched healthy controls were the subjects for the study. The subjects were screened for 13 polymorphisms and three mutations spread across seven different candidate genes involved in the hemostatic system. Of the 13 polymorphisms and three mutations studied, four polymorphisms, HPA-I, TAFI 147Ala > Thr, methylene tetrahydrofolate reductase (MTHFR) 677 C > T, and MTHFR 1298 A > C, showed significant association with the disease phenotype. MTHFR 677 C > T showed the strongest association and therefore may have a strong predisposing role for pediatric strokes. Gene-gene interaction studies showed a strong interaction between HPA-I and MTHFR 677 C > T polymorphism. The wild type of both these polymorphisms synergistically showed a strong protective effect [p < 0.0001, O.R: 10.06(4.26-23.71)]. Polymorphisms in HPA-I and MTHFR may have important predisposing roles in the development of pediatric stroke.
引用
收藏
页码:473 / 478
页数:6
相关论文
共 50 条
  • [41] Pharmacodynamic assessment of prasugrel and clopidogrel in patients with non-cardioembolic stroke: a multicenter, randomized, active-control clinical trial
    Takenori Yamaguchi
    Toshiaki Shirai
    Satoshi Yoshiba
    Kenji Abe
    Yasuo Ikeda
    Journal of Thrombosis and Thrombolysis, 2020, 49 : 10 - 17
  • [42] Tachycardia Changes Increase Neurological Deterioration in Patients with Acute Non-Cardioembolic Stroke: An ADS Post-Hoc Analysis
    Matsuzono, Kosuke
    Fujimoto, Shigeru
    Aoki, Junya
    Ozawa, Tadashi
    Kimura, Kazumi
    JOURNAL OF ATHEROSCLEROSIS AND THROMBOSIS, 2023, 30 (01) : 66 - 73
  • [43] Dyslipidemia in Acute Non-cardioembolic Ischemic Stroke Patients at a Tertiary Care Centre: A Descriptive Cross-sectional Study
    Shah, Surendra Prasad
    Shrestha, Aashish
    Pandey, Sirish Raj
    Sigdel, Kaushal
    Sah, Namrata
    Panthi, Sagar
    Basnet, Lila Bahadur
    JOURNAL OF NEPAL MEDICAL ASSOCIATION, 2022, 60 (247) : 241 - 245
  • [44] Clinical Profile Of Patients With Non-cardioembolic Ischemic Stroke Or Transient Ischemic Attack Benefiting Most From Dual Antiplatelet Therapy
    Qian, Shuo
    Trifan, Gabriela
    Testai, Fernando
    STROKE, 2022, 53
  • [45] Cerebral Blood Flow and Metabolism Associated with Cerebral Microbleeds in Patients with Non-cardioembolic Stroke Without Major Cerebral Arterial Stenosis
    Hashimoto, Tetsuya
    Yokota, Chiaki
    Shimomura, Ryo
    Koshino, Kazuhiro
    Uehara, Toshiyuki
    Morita, Naomi
    Nakagawara, Jyoji
    Minematsu, Kazuo
    Iida, Hidehiro
    Toyoda, Kazunori
    STROKE, 2015, 46
  • [46] Prevention (Other than Clinical Trials) Statin pretreatment is associated with initial stroke severity in non-cardioembolic ischemic stroke patients with dyslipidemia: The Fukuoka Stroke Registry
    Ishikawa, H.
    Wakisaka, Y.
    Makihara, N.
    Ago, T.
    Kuroda, J.
    Matsuo, R.
    Hata, J.
    Nakane, H.
    Kamouchi, M.
    Kitazono, T.
    INTERNATIONAL JOURNAL OF STROKE, 2015, 10 : 103 - 103
  • [47] Comparison of prasugrel and clopidogrel in patients with non-cardioembolic ischaemic stroke: a phase 3, randomised, non-inferiority trial (PRASTRO-I)
    Ogawa, Akira
    Toyoda, Kazunori
    Kitagawa, Kazuo
    Kitazono, Takanari
    Nagao, Takehiko
    Yamagami, Hiroshi
    Uchiyama, Shinichiro
    Tanahashi, Norio
    Matsumoto, Masayasu
    Minematsu, Kazuo
    Nagata, Izumi
    Nishikawa, Masakatsu
    Nanto, Shinsuke
    Abe, Kenji
    Ikeda, Yasuo
    LANCET NEUROLOGY, 2019, 18 (03): : 238 - 247
  • [48] Baseline platelet parameters for predicting early platelet response and clinical outcomes in patients with non-cardioembolic ischemic stroke treated with clopidogrel
    Li, Wenxian
    Xie, Xiaomei
    Wei, Di
    Zhang, Shijun
    Wu, Yuanling
    Fu, Xuejun
    Jing, Zhen
    Lu, Weibiao
    Lai, Xinqiang
    Huang, Li'an
    ONCOTARGET, 2017, 8 (55) : 93771 - 93784
  • [49] Risk of major cardiovascular events in patients with non-cardioembolic ischemic stroke and transient ischemic attack in Colombia: a subgroup analysis of the OPTIC registry
    Munoz-Collazos, M.
    Torres, G. F.
    Valenzuela, E. L.
    CEREBROVASCULAR DISEASES, 2013, 35 : 442 - 442
  • [50] Effects Of The Oral Factor XIa Inhibitor Asundexian On Intracranial Bleeding Among Patients With Acute Non-Cardioembolic Ischemic Stroke: PACIFIC-Stroke Randomized Trial
    Khatri, Pooja
    Shoamanesh, Ashkan
    Mundl, Hardi
    Smith, Eric
    Saad, Feryal
    Xu, Lizhen
    Heenan, Laura
    Colorado, Pablo
    Kirsch, Bodo
    Neumann, Christoph
    Connolly, Stuart J.
    Hart, Robert G.
    STROKE, 2023, 54